Formulations for Intermittent Release of Parathyroid Hormone (1-34) and Local Enhancement of Osteoblast Activities

ISSN： 1083-7450

Source： Pharmaceutical Development and Technology, Vol.13, Iss.6, 2008-11, pp. : 505-512

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Parathyroid hormone (1-34): a major advance in the treatment of osteoporosis?

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 11, 2001-11 ,pp. : 1919-1920

Informa Healthcare

Access to resources Recommend Favorite

Role of Matrix Gla Protein in Parathyroid Hormone Inhibition of Osteoblast Mineralization

Cells Tissues Organs, Vol. 181, Iss. 3-4, 2006-04 ,pp. : 166-175

Karger

Access to resources Recommend Favorite

Demonstrated Solid-State Stability of Parathyroid Hormone PTH(1–34) Coated on a Novel Transdermal Microprojection Delivery System

By Ameri Mahmoud Daddona Peter Maa Yuh-Fun

Pharmaceutical Research, Vol. 26, Iss. 11, 2009-11 ,pp. : 2454-2463

Springer Publishing Company

Access to resources Recommend Favorite

Parathyroid Hormone as an Anabolic Skeletal Therapy

By Rubin Mishaela R. Bilezikian John P.

Drugs, Vol. 65, Iss. 17, 2005-01 ,pp. : 2481-2498

Adis International

Access to resources Recommend Favorite

Pharmacological Regulation of Parathyroid Hormone Secretion

Current Pharmaceutical Design, Vol. 8, Iss. 23, 2002-10 ,pp. : 2077-2087

Bentham Science Publishers

Access to resources Recommend Favorite